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doi:10.1Objective: Recent advances in endovascular repair have put into question the role of open surgery on the de-
scending thoracic aorta. We evaluated our experience with replacement of the descending thoracic aorta using
hypothermic circulatory arrest.
Methods: FromMay 1989 to August 2008, 151 patients (mean age 62 15 years) had descending thoracic aorta
replacement using cardiopulmonary bypass and hypothermic circulatory arrest. Concurrent distal aortic arch
repair was performed in 71 patients (47%). Seventeen patients (11%) had emergency operation.
Results: The mean durations of bypass and circulatory arrest were 107  34 and 32  9 minutes, respectively.
Stroke occurred in 5 patients (3.3%), spinal cord ischemic injury in 2 patients (1.3%; 1 paraplegia, 1 paraparesis),
and renal failure requiring dialysis in 2 patients (1.3%). Thirty-day and 6-month mortality rates were 4.0% and
9.9%, respectively. Following emergency operation, the 30-day mortality rate was 17.6% compared with 2.2%
after elective surgery (P ¼ .02). Five- and 10-year survival rates were 71% and 45%, respectively. Five patients
required reoperation on the graft or contiguous aorta at a mean of 5  4 years after the initial repair. Five- and
10-year rates of freedom from reoperation were 96% and 92%, respectively.
Conclusions: Cardiopulmonary bypass with hypothermic circulatory arrest can be safely used for replacement of
the descending thoracic aorta. Although more invasive than endovascular stent grafting, this open surgical tech-
nique provides definitive repair, maintenance of left subclavian artery patency, protection against spinal cord
injury, and early mortality and morbidity rates that do not exceed those reported for endovascular repair. (J Thorac
Cardiovasc Surg 2010;139:249-55.)Several open operative strategies exist for themanagement of
disease involving the descending thoracic aorta (DTA), in-
cluding the single-clamp technique,1 distal perfusion with
left heart bypass,2 partial cardiopulmonary bypass (CPB),3
and hypothermic CPB with intervals of circulatory arrest.4
Recently, advances in endovascular repair of the DTA with
stent grafts have put into question the role of open operation.
Numerous series have been published confirming the feasi-
bility of DTA stent grafting for the management of aortic an-
eurysms, penetrating ulcers, type B dissections, and
traumatic transections.5-11 Because of its less invasive nature
and relative ease of performance, there exists a perception
that endovascular stent grafting of the DTA is associated
with reduced morbidity and mortality, including a lower
risk of spinal cord ischemic injury (SCII) and stroke, com-
pared with open repair.8,12-14 Although stent-graft repair
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The Journal of Thoracic and Caclamping,12,14 endovascular techniques are associated with
important risks. Recent reports have documented morbidity
and mortality rates ranging from 2% to 28%.10,15,16 More-
over, late complications have been reported, including endo-
leaks, graft migration, and aneurysm-related death.
Secondary interventions are not infrequent.5,6 With a grow-
ing trend away from traditional surgical repair, we reviewed
our contemporary experience with open DTA replacement
using CPB with hypothermic circulatory arrest (HCA).METHODS
Patient Characteristics
BetweenMay 1989 andAugust 2008, 151 patients hadDTA replacement
with left thoracotomy, CPB, and HCA. The clinical characteristics of the pa-
tients are shown in Table 1. The mean age at operation was 62  15 years
(range, 20–85), and 47patientswerewomen (31%). Ten patients had clinical
manifestations of Marfan syndrome (6.6%). Eighty-three (55%) had symp-
toms associated with their aortic disease. The remaining patients had aneu-
rysms that were more than twice the size of adjacent normal aorta or had
evidence of progressive aortic enlargement. Degenerative aneurysms were
present in 92 patients (61%). Twenty-five patients (17%) had chronic
type B dissections with aneurysm, and 7 patients (4.6%) presented with
complicated acute type B dissections. Seventeen patients (11%) had emer-
gency operation. Twenty-one patients (14%) had previous operations on
the DTA. The extent of the aortic disease requiring replacement is listed in
Table 2. The study was reviewed by the Institutional Review Board of the
Missouri Baptist Medical Center and was exempted from Board approval.
Operative Technique
Our general technique has been previously described.4 With increasing
experience, several modifications have been introduced. Since Septemberrdiovascular Surgery c Volume 139, Number 2 249
TABLE 1. Preoperative patient characteristics (n ¼ 151)
Patient characteristic No. of patients (%)
Comorbidity
Hypertension 122 (81%)
History of smoking 75 (50%)
Hyperlipidemia 69 (46%)
Chronic obstructive pulmonary disease 15 (10%)
Coronary artery disease 55 (36%)
Peripheral vascular disease 37 (25%)
Creatinine 1.5 mg/dL 19 (13%)
Previous transient ischemic attack or stroke 16 (11%)
Marfan syndrome 10 (6.6%)
Diabetes mellitus 6 (4.0%)
Previous operations
Coronary artery bypass grafting or
percutaneous coronary intervention
40 (26%)
Aortic valve procedure 30 (20%)
Ascending aortic repair 25 (17%)
Aortic arch repair 11 (7.3%)
Descending thoracic aortic repair 21 (14%)
Abdominal aortic aneurysm repair 28 (19%)
Etiology of aortic disease
Degenerative aneurysm 92 (61%)
Chronic type B dissection 25 (17%)
Acute type B dissection 7 (4.6%)
Aortic coarctation 11 (7.3%)
Other 16 (11%)
Abbreviations and Acronyms
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
DTA ¼ descending thoracic aorta
HCA ¼ hypothermic circulatory arrest
OR ¼ odds ratio
SCII ¼ spinal cord ischemic injury
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D2004, cerebrospinal fluid drainage has been used in 12 patients who required
extensive resection of the DTA. Following the insertion of monitoring cath-
eters, the induction of anesthesia, and the placement of a double-lumen en-
dotracheal tube, each patient was positioned in a right lateral decubitus
position with the hips turned to the left at a 45 angle. A posterolateral tho-
racotomy incision was made either in the fourth or fifth intercostal space.
Simultaneously, the left common femoral artery and vein were isolated
through an oblique incision in the skin crease of the groin. After heparin ad-
ministration (3 mg/kg), a long cannula (28F–34F) was inserted through the
left common femoral vein, and the tip was positioned in the right atrium un-
der transesophageal echocardiographic guidance. The femoral artery was
cannulated with an 18F to 22F short cannula. CPB was established, and
cooling was initiated with a target nasopharyngeal temperature of 15C to
17C. A catheter was placed through the left inferior pulmonary vein for
venting of the left heart. Patients with significant aortic valve regurgitation
(3–4þ) required surgical intervention on the valve prior to having operation
on the DTA.
In 1999, we modified our cannulation technique for 35 subsequently
treated patients with atherosclerotic disease and degenerative aneurysms.
In addition to standard femoral artery cannulation, a dispersion arterial can-
nula (Edwards Lifesciences Inc, Midvale, UT) was inserted directly into the
DTA at a noncalcified thrombus-free site identified by epiaortic ultrasonog-
raphy. The DTA cannula and the femoral cannula were then connected to
separate arterial lines from the pump oxygenator. In these patients, CPB
was established using the arterial line attached to the DTA cannula, and
the femoral line was clamped. This technique was utilized to reduce the
risk of retrograde embolization of thrombus or atheroma into the cerebral
circulation. Alternatively, if cannulation of the DTA was inadvisable due
to extensive atheromatous disease, a small left axillary incision was
made, and an 8-mm collagen-impregnated graft was anastomosed to the
left axillary artery to be used for proximal perfusion. The femoral arterial
line remained clamped while the patient was cooled. In all other cases, in-
cluding aortic dissection, the femoral artery was used to establish CPB. If
a long period of HCA was anticipated during performance of the proximal
anastomosis, a clamp was placed on the distal DTA, and low-flow perfusion
was established to the lower body through the femoral arterial line for pro-
tection of the spinal cord, kidneys, and visceral organs.
During the period of cooling, methylprednisone (7mg/kg) and thiopental
(10 to 15 mg/kg) were administered intravenously, and the head was packed
in ice. The aorta proximal and distal to the diseased segment was isolated
circumferentially. No cardioplegic solution was given, and no monitoring
of somatosensory or motor evoked potentials was used. When electroen-
cephalographic silence was achieved and the nasopharyngeal temperature
was 22C or less, circulatory arrest was established and the left heart vent
was discontinued. The diseased segment of DTA was incised and, if indi-
cated, the incision was extended into the aortic arch. The left phrenic, left
vagus, and left recurrent nerves were identified and protected. A collagen-
impregnated woven polyester aortic graft (26–32 mm) containing a 10-
mm side arm (Hemashield; Meadox Medicals, Inc, Oakland, NJ) was
sutured end-to-end to the transected proximal DTA or aortic archwith a con-
tinuous 3–0 or 4–0 polypropylene suture buttressed with a strip of felt. As
this suture line was completed, cold blood (10C–12C) from the pump ox-250 The Journal of Thoracic and Cardiovascular Surgygenator was infused retrogradely into the venous cannula to assist in the
evacuation of air and debris from the heart, upper circulation, and graft
(flow rate up to 800 mL/min, maximum central venous pressure 20 mm
Hg). The side arm of the graft was attached to the proximal arterial line
from the pump oxygenator. After evacuation of air, a clamp was placed
on the graft just distal to the side arm, and flow to the upper body was rees-
tablished at a rate of 15 to 20mL/kg/min and a temperature of 20C to 22C.
This minimized the interval of circulatory arrest and reestablished circula-
tion to the brain, vertebral arteries, and upper extremities.
Distally, the aortawas transected below the diseased segment, and the dis-
tal anastomosis was performed with a continuous 3–0 or 4–0 polypropylene
suture buttressed with a strip of felt. If technically feasible, this anastomosis
was performed with the distal DTA occluded while low-flow lower-body
perfusion was continued through the femoral arterial line. If not feasible,
the distal aortic clamp was removed after discontinuing flow, and an open
anastamosis was performed. As the distal suture line was being completed,
perfusion through the femoral arterial line was used to evacuate air and de-
bris. Additional air was evacuated from the graft through multiple puncture
sites created with an 18G needle. Flow from the femoral arterial line was
discontinued, the proximal clamp was removed, and full antegrade flow
was established from the proximal arterial line. Rewarming was then initi-
ated. Spontaneous defibrillation usually occurred when the nasopharyngeal
temperature reached 26C to 28C. When the bladder temperature reached
35C, the pulmonary vein venting catheter was removed and CPB was
discontinued.
Whenever the distal DTA was replaced, an attempt was made to reim-
plant patent intercostal arteries. Patent arteries below the level of the sixth
or seventh intercostal space were reimplanted when technically feasible, as-
suming the aortic tissue surrounding the arteries was of adequate quality.
This was accomplished in 22 (34%) of the 65 patients who had distal
DTA replacement. If possible, the clamp on the aortic graft was repositioned
below the intercostal artery-to-graft anastomosis before the distalery c February 2010
TABLE 2. Extent of aortic repair
Extent of repair No. of patients
Proximal DTA
With distal arch 58
Without distal arch 28
Entire DTA
With distal arch 13
Without distal arch 35
Distal DTA 17
Total 151
DTA, Descending thoracic aorta.
TABLE 4. Extent of repair and associated morbidity and mortality
Extent of repair
30-d
mortality Stroke
Spinal cord
ischemic injury Dialysis
Proximal DTA
With distal arch
(n ¼ 58)
1 4 0 1
Without distal arch
(n ¼ 28)
0 1 0 0
Entire DTA
With distal arch (n ¼ 13) 1 0 1 0
Without distal arch
(n ¼ 35)
3 0 1 1
Distal DTA (n ¼ 17) 1 0 0 0
Total (n ¼ 151) 6 (4.0%) 5 (3.3%) 2 (1.3%) 2 (1.3%)
DTA, Descending thoracic aorta.
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Danastomosis was performed to permit early perfusion of the implanted inter-
costal arteries. In 10 patients (7%), continuity of the left subclavian artery
was maintained with an 8- to 10-mm collagen-impregnated graft inserted
between the aortic graft and the subclavian artery.
A membrane oxygenator (Optima XP; Cobe Cardiovascular, Arvada,
Colo) was used in all cases. The mean durations of cooling, circulatory ar-
rest, low-flow hypothermic bypass, hypothermic ventricular fibrillation, re-
warming, and CPB are shown in Table 3. The mean duration of circulatory
arrest was 31.7 9.4 minutes. A period of hypothermic low flow to the up-
per body after attachment of the aortic graft to the proximal aorta was used in
86 patients (mean duration, 25.4 14.3 minutes) to minimize the interval of
circulatory arrest.
Follow-up
After hospital discharge, patients were evaluated at 1 and 6 months post-
operatively and subsequently at 12-month intervals. Computed tomography
scans were obtained prior to discharge, at 6 months, and yearly thereafter.
Follow-up was 100% complete. Mean duration of follow-up was 4 years
(range, 1 month to 18 years).
Statistical Analyses
Data were analyzed in Intercooled Stata 9.2 (Stata, College Station, Tex).
Standard descriptive statistical analyses were used. Continuous data, pre-
sented as a mean  standard deviation, were compared between groups
using unpaired 2-sided Student t tests. Categorical data, presented as propor-
tions, were compared between groups using Fisher exact test. Nonparamet-
ric estimates of freedom from all-cause death and reoperation were
determined using the Kaplan-Meier method. A composite outcome was de-
veloped that incorporated the adverse perioperative events of 30-day mor-
tality, SCII, stroke, and need for dialysis. Predictors of adverse
perioperative events were determined with multivariate logistic regression.
Multivariate models were developed by incorporating variables that hadTABLE 3. Cardiopulmonary perfusion data
Mean ± SD Range
Time (min)
Cardiopulmonary bypass 107.2  33.9 57–346
Cooling 32.2  8.7 18–61
Circulatory arrest 31.7  9.4 11–53
Low-flow hypothermic bypass* 25.4  14.3 5–81
Hypothermic ventricular fibrillation 76.8  21.1 30–140
Rewarming 57.7  13.0 30–115
Temperature (C)
Lowest nasopharyngeal 15.4  2.1 11–22
Lowest bladder/rectal 20.0  3.1 13–28
SD, Standard deviation. *Eighty-six patients.
The Journal of Thoracic and Caa P value of .20 or less on univariate testing. Stepwise forward selection
and backward elimination techniques were employed with P¼ .20 for entry
and removal criteria. Odds ratios (ORs) are reported with 95% confidence
intervals (CIs).RESULTS
Early Mortality
The 30-day mortality rate for the entire group was 4.0%
(6 patients). The mortality according to the extent of aorta
replaced is summarized in Table 4. In patients who had
previous operation on the DTA, the 30-day mortality
was 9.5%, compared with 3.1% in those who had not
(P¼ .20). Following emergent operation, the 30-day mortal-
ity rate was 17.6% compared with 2.2% after elective sur-
gery (P ¼ .02). Among patients treated as emergencies, 1
patient died intraoperatively due to myocardial failure dur-
ing a repair of a ruptured chronically dissected aorta. She
had previously had open repair and stent-graft repair of the
DTA, and she was known preoperatively to have left ventric-
ular dysfunction. One patient died from right ventricular fail-
ure 2 days after an emergency repair of a ruptured aneurysm,
and another died from cardiac arrest 20 days after emergency
repair of a ruptured aneurysm. The latter patient’s postoper-
ative course was complicated by deep vein thrombosis and
renal failure requiring dialysis. After elective surgery, 1 pa-
tient died from a cardiac arrest 9 days following an aneurysm
repair, 1 died 23 days after operation from a stroke that de-
veloped 12 days postoperatively, and 1 died 26 days after an-
eurysm repair from severe chronic obstructive pulmonary
disease and respiratory failure. Two additional patients
died during the hospital stay from complications of sepsis,
46 days after an elective reoperation and 93 days after an
emergency operation. Three other patients died within 6
months of surgery (causes: sepsis, cardiac arrest, and cardiac
tamponade). The 6-month mortality rate was 9.9%.Neurologic Complications
SCII occurred in 2 patients (1.3%), both prior to the rou-
tine use of cerebrospinal fluid drainage. Neurologic injuryrdiovascular Surgery c Volume 139, Number 2 251
TABLE 5. Postoperative morbidity (n ¼ 151)
Type of morbidity No. of patients (%)
Exploration for bleeding 6 (4.0%)
Low cardiac output (inotropes>48 h) 3 (2.0%)
Renal dysfunction requiring dialysis 2 (1.3%)
Gastrointestinal bleeding or ischemia 9 (6.0%)
Deep vein thrombosis or pulmonary embolus 9 (6.0%)
Pneumonia 33 (22%)
Wound infections 4 (2.6%)
Sepsis 4 (2.6%)
FIGURE 1. Long-term survival after descending thoracic aorta repair
among the entire cohort. CI, Confidence interval.
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Daccording to the extent of aorta replacement is listed in Table
4. Paraplegia developed after replacement of the entire DTA
in 1 patient who had previously had repair of an infrarenal
abdominal aortic aneurysm 1 year earlier. During his DTA
operation, intercostal arteries at T6, T8, and T10 were
judged not to be implantable and were oversewn. When
the neurologic injury became apparent on postoperative
day 1, a spinal drain was inserted, but no neurologic recov-
ery occurred. Another patient developed paraparesis after re-
placement of the entire DTA and distal aortic arch. During
her DTA operation, intercostal arteries at T7, T8, and T10
were oversewn, and no other intercostals were reimplant-
able. Her neurologic function returned completely.
Five patients (3%) had a stroke. Four of these patients had
stroke prior to the routine use of proximal perfusion through
a DTA cannula. Among the 92 patients with degenerative
atherosclerotic aneurysms, the stroke rate was 2.9% (1 out
of 35) with the use of DTA cannulation, compared with
5.3% (3 out of 57) with the sole use of femoral artery can-
nulation. Bilateral cerebellar infarcts developed in the pa-
tient who had a stroke using the contemporary strategy of
DTA cannulation, likely from embolization of extensive ath-
eromatous material found in the aorta adjacent to the origin
of the left subclavian artery.Other Morbidity
Intraoperative transfusion of blood products was required
in 121 patients (80%). Average intraoperative transfusion
requirements were 5.0  3.6 U (median, 4 U) of packed
red blood cells, 4.2  2.6 U (median, 4 U) of fresh frozen
plasma, and 2.8  2.0 U (median, 2 U) of platelets. Ventila-
tory support was required for a mean of 3  10 days (me-
dian, 1 day), and 8 patients (5%) required temporary
tracheostomy. The duration of intensive care unit stay was
6  9 days (median, 4 days). Hospital length of stay was
16  15 days (median, 11 days). Additional morbidity
data are listed in Table 5.
The composite outcome (incorporating 30-day mortality,
SCII, stroke, and need for dialysis) occurred in 13 patients
(9%). Predictors associated with the composite outcome
on univariate analysis included older age (OR: 1.1 per
each additional year; 95% CI: 1.0, 1.2; P ¼ .01), increasing252 The Journal of Thoracic and Cardiovascular Surgduration of CPB (OR: 1.1 per each additional 10 minutes;
95% CI: 1.0, 1.3; P¼ .05), previous abdominal aortic aneu-
rysm repair (OR: 2.7; 95% CI: 0.7, 9.7; P ¼ .13), the pres-
ence of coronary artery disease (OR: 3.1; 95% CI: 0.9, 9.9;
P ¼ .06), the presence of peripheral vascular disease (OR:
2.9; 95% CI: 0.9, 9.3; P¼ .07), and the need for emergency
surgery (OR: 6.6; 95% CI: 1.9, 23.2; P ¼ .004). On multi-
variate logistic regression, independent predictors of the
composite outcome were the need for emergency surgery
(adjusted OR: 11.8; 95% CI: 2.1, 66.6; P¼ .005), and older
age (adjusted OR: 1.1 per each additional year; 95% CI: 1.0,
1.2; P ¼ .02).Long-term Follow-up
During the follow-up period that extended to 18 years,
there were 35 late deaths. Five- and 10-year survival rates
were 71% and 45%, respectively (Figure 1). Patients with
degenerative aneurysms had 5- and 10-year survival rates
of 66% and 32%, compared with 80% and 75% among
all other patients (P ¼ .003; Figure 2). Five patients needed
reoperation on the graft or contiguous aorta at a mean of 5
4 years after the initial procedure. Indications for reoperation
included a bleeding intercostal patch 3 weeks postopera-
tively (1), late aneurysmal dilatation of the intercostal patch
(2), or progressive dilatation of the proximal (1), or distal
DTA (1). Five- and 10-year actuarial rates of freedom from
reoperation were 96% and 92%, respectively (Figure 3).
The remaining patients are free of symptoms and abnormal
findings of the contiguous aorta on serial computed tomogra-
phy examinations from 1 month to 18 years postoperatively.DISCUSSION
The optimal open surgical technique for the management
of disease involving the DTA has yet to be established.
A number of operative strategies exist, including theery c February 2010
FIGURE 2. Long-term survival after descending thoracic aorta repair
among patients treated for degenerative or nondegenerative aneurysms.
Long-term survival was significantly better in patients with nondegenerative
aneurysms. CI, Confidence interval.
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Dsingle-clamp technique,1 distal perfusion with left heart by-
pass,2 and partial CPB.3 Hypothermic CPB with intervals of
circulatory arrest has proven to be a safe and effective means
for protection of the central nervous system during complex
cardiac surgery. Applying this technique to the repair of the
DTA provides a bloodless field and access to the aortic arch,
as well as eliminating the need for proximal and sequential
aortic clamping, extensive mobilization of the aorta, and
monitoring of evoked potentials. The majority of the shed
blood is returned to the perfusion circuit, and excellent pro-
tection of the central nervous system, the heart, and the vis-
cera is provided by hypothermia. Through the process of
metabolic down-regulation, HCA increases ischemic toler-
ance and allows for an unhurried aortic reconstruction inFIGURE 3. Freedom from reoperation on the graft or contiguous aorta af-
ter descending thoracic aorta repair. CI, Confidence interval.
The Journal of Thoracic and Caaddition to the identification and reimplantation of intercos-
tal arteries.
First described in 1994,17 stent-graft repair has gradually
gained favor as a treatment option for DTA pathology. Al-
though initially applied for degenerative aneurysms of the
DTA, endovascular techniques are increasingly being used
in the management of traumatic transections, acute and
chronic dissections, and penetrating ulcers. Recently, aneu-
rysms of the aortic arch and thoracoabdominal aorta have
been treated with investigational hybrid and debranching en-
dovascular techniques. These advances have put into ques-
tion the role of open DTA surgery in the modern era.
Arguments in favor of these novel endovascular therapies
often refer to high morbidity and mortality rates reported
in surgical series published more than 20 years ago.11,17,18
With a growing movement away from open surgical re-
pair, the goal of the current study was to present contempo-
rary surgical outcomes using CPB and HCA during repair of
the DTA. Our results illustrate that, when applied on a rou-
tine basis, DTA repair using HCA is a safe and durable pro-
cedure. Adverse neurologic events occurred infrequently,
with SCII and stroke occurring in 1.3% and 3.3% of pa-
tients, respectively. Thirty-day mortality was 4.0%, driven
mostly by the 17.6% mortality rate among patients treated
as emergencies. In contrast, elective repair was associated
with a 30-day mortality of 2.2%, a stroke rate of 3.0%,
and SCII rate of 1.5%. Independent risk factors associated
with adverse perioperative events included the need for
emergency surgery and older age. Five patients required re-
operation on the graft or contiguous aorta at a mean of 5 4
years after the initial repair, and the 10-year rate of freedom
from reoperation was 92%. In our view, these results com-
pare favorably with those currently reported for endovascu-
lar repair 5-12,15,16,19 and confirm that CPB with HCA is
a reliable and effective technique for repair of the DTA.
Hypothermia is a valuable adjunct for the treatment of
complex aortic disease and has been shown to reduce the in-
cidence of postoperative neurologic deficits.20 Early in our
experience, we selectively applied CPB with HCA in the
presence of extensive descending aortic disease involving
the distal aortic arch, when the risk of paraplegia was judged
to be increased, or when we felt that clamping of the proxi-
mal aorta was unsafe due to severe atherosclerosis. Over
time, however, we have used CPB with HCA on a routine
basis for all patients with extensive aneurysms and dissec-
tions of the DTA and in patients with thoracoabdominal aor-
tic aneurysms.4 Hypothermia remains the most effective
intervention for protecting neural tissue against ischemic
injury.
The results reported herein add to other contemporary
series involving open surgical repair of the DTA. Using
the classic clamp-and-sew technique in 132 patients, Cooley
and colleagues1 reported a 30-day mortality rate of 12.9%
and SCII rate of 8.3%. In comparison, results have generallyrdiovascular Surgery c Volume 139, Number 2 253
TABLE 6. Contemporary risks associated with endovascular stent-graft repair of the descending thoracic aorta
Authors No. of patients 30-d mortality (%) Spinal cord ischemic injury (%) Stroke (%) Renal failure requiring dialysis (%)
Patel et al5 73 5.5 4.1 8.2 4.1
Hughes et al7 83 3.6 6.0 3.6 —
Stone et al6 105 6.7 6.7 9.5 —
Brown et al8 116 5.2 2.6 8.6 2.6
Bavaria et al19 140 2.1 2.9 3.6 1.4
Makaroun et al10 142 1.5 2.8 3.5 —
Wheatley et al9 158 3.8 2.5 2.5 2.5
Greenberg et al12 163 4.9 0.6 — —
Leurs et al15 443 9.3 2.5 2.2 —
Fattori et al16 457 5.0 1.8 3.7 0.9
Buth et al11 606 9.9 2.5 3.1 —
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Dbeen better in series where neuroprotective adjuncts have
been applied, including distal aortic perfusion and cerebro-
spinal fluid drainage. In a series of 300 elective patients
with DTA aneurysms, Estrera and associates2 reported
a 30-day mortality rate of 8% and SCII in 2.3% of patients.
The incidence of neurologic deficits was lower in those pa-
tients who had repair with both left heart bypass and cerebro-
spinal fluid drainage compared with those who did not
(1.3% vs 6.5%, P< .02). Minatoya and coworkers21 re-
cently reported their experience using partial CPB to replace
the DTA in 112 patients. The early mortality rate was 5.3%.
Similar to our experience, their elective mortality rate
(1.0%) was much lower compared with emergency cases
(31.3%). The stroke rate was 7.1%, and SCII occurred in
2.7%. Applying the technique of CPB with HCA for DTA
repair in 132 patients, Patel and colleagues22 documented
a 30-day mortality of 6.0%, SCII 4.5%, and dialysis-depen-
dent renal failure in 5.3%. The incidence of stroke, 6.8%,
was somewhat higher compared with our experience, possi-
bly related to their exclusive use of femoral artery cannula-
tion. Cannulation of the DTA or the left axillary artery may
lower the risk of retrograde embolization and stroke, partic-
ularly in patients with degenerative aneurysms. Although
concerns have been raised regarding excessive bleeding
and respiratory complications with HCA, our results com-
pare favorably to those reported from centers applying alter-
native surgical techniques.1-3,21,22
Endovascular stent-graft repair is an attractive option for
the treatment of DTA disease. Endovascular repair features
incisions limited to the groin, minimal organ ischemia,
less blood loss and fluid shifts, and a lower stress on the car-
diopulmonary system.12 Optimism for stent-graft repair was
generated from the report of the initial Gore TAG trial that
led to the US Food and Drug Administration approval. A
carefully selected group of patients with degenerative aneu-
rysms were recruited into the stent-graft arm of the study
based on strict inclusion and exclusion criteria. For compar-
ison, a surgical group enrolled historical and concurrent sub-
jects treated with a variety of different operative techniques.
Favorable outcomes were reported with the Gore TAG graft,254 The Journal of Thoracic and Cardiovascular Surgincluding 30-day rates of death, stroke, and SCII of 2.1%,
3.6%, and 2.9%, respectively.19 With encouraging early
stent-graft results, a claim has consistently been made in
the literature that, compared with conventional open repair,
stent grafting of the DTA is associated with reduced morbid-
ity and mortality, including a lower risk of SCII and
stroke.8,12-14
Although no randomized trials exist, more recent stent-
graft series have documented morbidity and mortality rates
that do not differ substantially from those with open repair
(Table 6). The European Collaborators on Stent/Graft Tech-
niques for Aortic Aneurysm Repair (EUROSTAR) database
recently reported outcomes involving 606 patients treated
with DTA endovascular repair. The 30-day mortality was
9.9%, SCII developed in 2.5%, and stroke occurred in
3.1%,11 results that are comparable to those reported in
the current study. A recent systematic review compared
DTA outcomes from the 5 largest series of open surgical re-
pair (1716 cases) to pooled data from the 17 largest series of
endovascular stent-graft repair (1342 cases).23 Outcomes
were nearly identical for open surgery compared with
stent-graft repair (operative mortality rate: 4.8% vs 6.3%,
open vs stent, P ¼ .51; paraplegia: 2.9% vs 1.4%, open
vs stent, P ¼ .11; stroke: 3.2% vs 2.4%, open vs stent,
P ¼ .52). Importantly, late complication rates have not
been infrequent in published series, including endoleaks,
graft migration, need for open operation, and aneurysm-
related death. During short follow-up intervals, secondary
interventions have been required in 6% to 12% of pa-
tients.5-11 Long-term performance remains unknown.
In general, we favor open surgical repair for the treatment
of DTA pathology, particularly in patients at low operative
risk, those with connective tissue disorders or chronic aortic
dissections, and in younger patients who may benefit from
the excellent long-term durability and low reintervention
rate associated with open repair. However, we acknowledge
that stent-graft repair has an important role in the manage-
ment of select patients with DTA disease. Elderly patients
and those with severe comorbidities, including poor cardiac
and pulmonary reserve, appear to be ideal candidates for thisery c February 2010
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Dless invasive procedure, keeping in mind the poor long-term
survival of patients who are unsuitable for conventional
open surgical repair.24 Since August 2005, we have per-
formed stent-graft repair in 16 patients with DTA disease.
We have restricted stent-graft implantation to patients with
either degenerative aneurysms or penetrating ulcers that
have adequate anatomic landing zones. Patients with suture
line pseudoaneurysms or intercostal patch aneurysms fol-
lowing previous open aortic repair are also suitable candi-
dates,25 if the anatomy is favorable for stent-graft exclusion.Limitations
This study is the largest to date to report outcomes associ-
ated with DTA repair using CPB with HCA. However, the
results presented must be interpreted within the context of
the study design. Observational in nature, this study in-
volved the retrospective review of prospectively collected
data in a referral-based tertiary care center. Surgical tech-
niques evolved during the 20-year period of the study. Al-
though many patients were referred from afar, every effort
was made to obtain imaging surveillance at regular intervals,
even if from a distance. Patient outcomes were documented
by direct examination or through communication with fam-
ily members or referring physicians.CONCLUSIONS
In summary, we have documented that CPB with HCA
can be safely used in the replacement of the DTA and the dis-
tal aortic arch when necessary. Although more invasive than
endovascular stent-graft placement, this open surgical tech-
nique provides definitive repair, maintenance of left subcla-
vian artery patency, a low incidence of reoperation, and early
mortality and morbidity rates that do not exceed those
reported for endovascular repair.References
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